LX111
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LX111, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients [EARLY_Phase 1]